Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tenon Medical, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.036 Greetings, and welcome to the Tenon Inc. Second Quarter 2025 Earnings Conference Call. 00:00:05.036 -- 00:00:08.699 At this time, all assistance is in only mode. 00:00:08.699 -- 00:00:12.342 A brief question and answer session will follow the formal presentation. 00:00:12.342 -- 00:00:17.187 If anyone should require operator's assistance during the conference, please press star 00:00:17.187 -- 00:00:22.151 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:22.151 -- 00:00:26.996 It is now my pleasure to introduce your host, Stephen Foster, CEO and President. 00:00:26.996 -- 00:00:29.937 Thank you. You may begin. 00:00:29.984 -- 00:00:32.789 Thank you, Maria, and good afternoon, everyone. 00:00:32.789 -- 00:00:37.937 I'm pleased to welcome you to today's second quarter 2025 financial results and 00:00:37.937 -- 00:00:41.423 corporate update conference call for Tenon Medical. 00:00:41.423 -- 00:00:46.331 We recently marked a pivotal step forward for Tenon Medical, highlighted by a strategic 00:00:46.331 -- 00:00:51.940 acquisition on top of a second quarter that included continued clinical validation 00:00:51.940 -- 00:00:55.165 and meaningful progress towards diversification 00:00:55.165 -- 00:01:00.167 of our product offerings. Speaking to our recent announcement, a significant focus 00:01:00.167 -- 00:01:05.154 of our second quarter initiatives was the thorough due diligence and successful completion 00:01:05.154 -- 00:01:09.981 of the strategic acquisition of SciVantage, which we announced subsequent to quarter 00:01:09.981 -- 00:01:15.449 end. With integration to take place over the next 60 to 90 days, this transaction 00:01:15.449 -- 00:01:20.656 delivers active case value, revenue generating...